Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Synovial Sarcoma, X Breakpoint 4B (SSX4B) (Middle Region) Peptid

SSX4B Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN984477
  • Target Alle SSX4B Produkte
    SSX4B (Synovial Sarcoma, X Breakpoint 4B (SSX4B))
    Protein Region
    Middle Region
    Spezies
    Human
    Quelle
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    MRSKRAADFH GNDFGNDRNH RNQVERPQMT FGSLQRIFPK IMPKKPAEEE
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-SSX4B Antibody(ARP50423_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Each Investigator should determine their own optimal working dilution for specific applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    SSX4B (Synovial Sarcoma, X Breakpoint 4B (SSX4B))
    Synonyme
    CT5.4 Peptide, SSX family member 4B Peptide, SSX4B Peptide
    Hintergrund
    The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. Chromosome Xp11 contains a segmental duplication resulting in two identical copies of synovial sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail orientation. This gene, SSX4B, represents the more centromeric copy. Two transcript variants encoding distinct isoforms have been identified for this gene.

    Alias Symbols: SSX4, CT5.4

    Protein Interaction Partner: HIF1A

    Protein Size: 188
    Molekulargewicht
    22 kDa
    Gen-ID
    548313
    NCBI Accession
    NM_001034832, NP_001030004
    UniProt
    O60224
Sie sind hier:
Kundenservice